放射性核素刺激的动态疗法诱导了补充免疫性亡和亡的癌细胞死亡途径
Christopher Egbulefu1,2, Kvar Black2, Xinming Su3
1Department of Biomedical Engineering, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
Communications biology
|January 19, 2026
概括
放射性核素刺激动态疗法 (RaST) 通过亡和亡引发癌细胞死亡. 在免疫能力强的模型中,RaST有效控制瘤并通过重编程抗瘤免疫力来预防转移.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 纳米医学是一种纳米医学.
背景情况:
- 放射性核素刺激动态疗法 (RaST) 使用Cerenkov辐射激活光敏药物,产生反应性氧物种 (ROS) 抑制癌症.
- 精确的细胞死亡机制和RaST诱导的免疫反应仍然不完全理解.
研究的目的:
- 为了阐明由RaST激活的细胞死亡途径.
- 在免疫能力和免疫缺陷的临床前癌症模型中评估RaST的疗效.
- 为了研究免疫系统在RaST介导的瘤控制中的作用.
主要方法:
- 使用ROS再生纳米光敏剂与转素-泰坦复合物,用放射性标记的2-氧糖.
- 评估细胞死亡机制,包括细胞亡和亡标记 (RIPK-1,RIPK-3,NF-κB,MLKL).
- 评估了免疫能力和免疫缺陷小鼠的瘤生长,转移和免疫细胞透.
主要成果:
- RaST诱导的亡和亡,其特征是特定的分子标记物和免疫刺激损伤相关的分子模式.
- 在免疫缺陷小鼠中,RaST未能阻止瘤生长.
- 在免疫能力强的小鼠中,RaST实现了部分和完整的反应,防止转移并招募效应性免疫细胞 (CD11b+,CD11c+,CD8b+).
- 一种癌症成像剂 (LS301) 在响应者中检测到最小的残留疾病.
- 通过纳米粒子再分配实现了持续的瘤控制,并保持了免疫力,尽管有不断变化的前瘤因素.
结论:
- 通过诱导亡和亡,RaST有效地重编程瘤免疫,克服对亡的抵抗力.
- 在免疫能力强的宿主中,RaST的抗瘤疗效严重依赖于完整的免疫系统.
- 拉斯特显示出作为一种免疫性癌症治疗的潜力,能够根除已有的瘤并防止复发.
相关概念视频
01:44Complementary DNA
31.3K
Overview
31.3K
02:49Cancer Therapies
9.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.9K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:30Apoptosis
14.2K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
14.2K
01:30Overview of Cell Death
9.5K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.5K
01:18Autophagic Cell Death
4.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.4K